52-Week Performance Chart

Powered by FactSet Research Systems Inc

Recent Company News

More

Powered by FactSet Research Systems Inc.

Corporate Actions/Books Closed

Go to Archived DR Corporate Actions

Capital Raising Events

More
DR Price Date DR Price (USD) US/Non-US/Total DRS US/Non-US/Total DR Capital Raised
Dec 02, 2015 62.50 59,400,000
0
59,400,000 		3,712,500,000
0
3,712,500,000

No DR Special Notices are available.

Recent Dividends & Distributions

More
US RECORD DATE US PAYABLE DATE NET DR AMOUNT
Aug 15, 2012 Sep 04, 2012 0.2083
May 21, 2012 Jun 04, 2012 0.1960
Feb 27, 2012 Mar 13, 2012 0.1972
Nov 14, 2011 Dec 07, 2011 0.1719

Institutional Ownership

More
TOP INSTITUTIONAL HOLDERS POSITION
Fidelity Management & Research Co. LLC 73,244,422
ION Asset Management Ltd. (Israel) 39,033,500
Clal Pension & Provident Funds Ltd. 37,794,068
TOP MUTUAL FUND HOLDERS POSITION
Fidelity Contrafund 17,356,978
iShares Core MSCI EAFE ETF 7,226,058
Fidelity Contrafund Commingled Pool 6,838,085

Data provided by FactSet Research Systems Inc.

DR Details

DR Symbol TEVA
CUSIP 881624209
DR Venue New York Stock Exchange
DR ISIN US8816242098
Ratio DR:ORD 1:1
Underlying ISIN IL0006290147
Country Israel
Effective Date Dec 04, 2018
Depositary CIT (Sponsored)
Industry Pharma. & Biotech.
Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, the Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.

Data provided by Mergent, Inc.

Fee Type in US Dollar per ADS Deposit Agreement
Cable Fee per Cancellation $17.5000

Monthly Trading Summary

More
Month Month End DR Close Price DR Trading Volume Avg Day DR Trading Volume
Jun.25 16.76 213,355,663 10,667,783
May.25 16.78 291,326,869 13,872,708
Apr.25 15.51 252,147,409 12,007,019

Powered by FactSet Research Systems Inc.

This information and data is provided for general informational purposes only.  Certain displayed prices may not reflect direct quotes from any market or exchange, but may instead reflect an approximation of price based on a methodology that includes a calculation that includes the price of underlying securities and foreign exchange rate selected for such purpose. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to Terms of Use

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE

Data provided by Thomson Reuters, Inc.

BNY.COM TERMS OF USE PRIVACY POLICY

© 2025 The Bank of New York Mellon Corporation. Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Quotes delayed at least 15 minutes. Market data provided by ICE Data Services. ICE Limitations.
News provided by Comtex News Network and MarketWatch. Powered and implemented by FactSet. Legal Statement.

Certain information included in this website is proprietary to Mergent, Inc. (Mergent) Copyright © 2003-2025. Reproduction of such information in any form is prohibited. Because of the possibility of human or mechanical error by Mergent's sources, Mergent or others, Mergent does not guarantee the accuracy, adequacy, completeness, timeliness or availability or for the results obtained from the use of such information. Mergent Terms of Use apply

Holdings information provided by FactSet Research Systems Inc. Copyright © 2003-2025 FactSet Research Systems Inc. All rights reserved.

Thomson Reuters Marks: The THOMSON REUTERS Kinesis Logo depicted below and THOMSON REUTERS

Redistributor shall display or print the Thomson Reuters Trademarks when Redistributor's Customers are given access to the Services.

Where Redistributor makes available on display any and all Thomson Reuters Marks attributable to the Services, Redistributor shall include the following language in the Help About section or in a general attribution page: "The THOMSON REUTERS Kinesis Logo and THOMSON REUTERS are trademarks of Thomson Reuters and its affiliated companies in the United States and other countries and used herein under license."

Additional Attribution Guidelines by Thomson Reuters: Redistributor shall display or print the following notice in the Help About section or in a general attribution page. "Copyright ©, Thomson Reuters, 1999-2025. All Rights Reserved. Use, duplication, or sale of this service, or data contained herein, except as described in the [Authorized Products name] Subscription Agreement, is strictly prohibited."

THOMSON REUTERS